Korean
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

dizziness/비만증

링크가 클립 보드에 저장됩니다.
페이지 1 ...에서 172 결과

Impact of dizziness and obesity on the prevalence of falls and fall-related injuries.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
OBJECTIVE Quantify the relationships between dizziness, falls, and obesity among adults. METHODS Cross-sectional analysis of a national health survey. METHODS Adult respondents in the 2008 National Health Interview Survey balance module were analyzed. With demographic information, data for balance

Dizziness and Falls in Obese Inpatients Undergoing Metabolic Rehabilitation.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
OBJECTIVE The relationship between dizziness and falls in the obese population is a relatively unexplored issue. The aims of the present study were to define the 1-year prevalence of dizziness in an obese inpatient population undergoing metabolic rehabilitation and to investigate possible
BACKGROUND The symptomatic sick sinus syndrome presents a classic indication for the implantation of a dual-chamber pacemaker according to the current national and international guidelines. However, in cases where dizziness and near syncope due to a sinus node dysfunction are found together with

In response to Impact of dizziness and obesity on the prevalence of falls and fall-related injuries.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입

In reference to Impact of dizziness and obesity of the prevalence of falls and fall-related injuries.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입

[Lowering blood pressure in an obese patient with long-term hypertension. Using a fixed combination of enalapril/hydrochlorothiazide].

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
A 50-year-old very obese man had suffered from hypertension for more than 20 years and had undergone various treatment regimens, the last being with an ACE inhibitor. Since his hypertension had nevertheless increased, and he developed dizziness and headaches, a combination of ACE-inhibitor and

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
BACKGROUND Rimonabant, a selective cannabinoid type 1 receptor blocker, reduces bodyweight and improves cardiovascular and metabolic risk factors in non-diabetic overweight or obese patients. The aim of the RIO-Diabetes trial was to assess the efficacy and safety of rimonabant in overweight or obese

Rimonabant: a novel selective cannabinoid-1 receptor antagonist for treatment of obesity.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
OBJECTIVE The pharmacology, pharmacokinetics, clinical efficacy, safety, drug interactions, and dosage and administration of rimonabant in the treatment of obesity and related metabolic factors are reviewed. CONCLUSIONS Discovery of the cannabinoid receptors has led to the development of rimonabant,
Taranabant is a novel cannabinoid CB-1 receptor (CB1R) inverse agonist in clinical development for the treatment of obesity. This double-blind, randomized, placebo-controlled, single oral dose study evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of taranabant (0.5-600 mg)

Fenfluramine lowers plasma norepinephrine in overweight subjects.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
The effect of fenfluramine on sympathetic nervous system activity was determined in 12 normotensive, obese men. Supine plasma norepinephrine (NE) concentrations decreased (p less than 0.001) from pretherapy levels (298 +/- 39 pg/ml) after one (166 +/- 30 pg/ml) and four weeks (171 +/- 28 pg/ml) of
OBJECTIVE To evaluate the efficacy and safety of taranabant in overweight and obese patients with type 2 diabetes mellitus (T2DM). METHODS This was a multicenter, double-blind, randomized, placebo-controlled study in overweight and obese patients with T2DM (ages > or = 18 and < or = 75 years) with a

Efficacy and Safety of Lorcaserin in Obesity: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
Lorcaserin is a novel, selective 5-hydroxytryptamine 2C serotonin receptor agonist, approved for the treatment of obesity. Several phase 3 randomized controlled trials (RCTs) trials have shown a significant reduction in body weight with lorcaserin.We

Short-term topiramate treatment does not improve insulin sensitivity or secretion in obese insulin-resistant women.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
OBJECTIVE Long-term treatment with topiramate reduces body weight and improves insulin sensitivity in obese humans. Our aim was to evaluate the effect of topiramate treatment for 4 weeks on insulin sensitivity and secretion, independent of weight loss. METHODS Randomized, double-blind, crossover,
OBJECTIVE To compare the Galletti-Contrino manoeuvre with the more widely used Semont-Toupet in overweight subjects presenting with benign paroxysmal positional vertigo (BPBV) of vertical semicircular canals (posterior and anterior canals). METHODS Prospective cohort study. METHODS 204 patients (BMI

[Effectiveness and safety of Very Low Calory Diets in obese patients].

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
OBJECTIVE To evaluate effectiveness, safety and adherence of Very Low Calory Diet (VLCD) in patients with obesity. METHODS Observational prospective descriptive study. Patients with BMI >30 kg/m2 who started VLCD were included. We arranged 3 pharmacotherapeutical consultations, picking up the
페이스 북
페이지에 가입하세요

과학이 뒷받침하는 가장 완벽한 약초 데이터베이스

  • 55 개 언어로 작동
  • 과학이 뒷받침하는 약초 치료제
  • 이미지로 허브 인식
  • 인터랙티브 GPS지도-위치에 허브 태그 지정 (출시 예정)
  • 검색과 관련된 과학 출판물 읽기
  • 효과로 약초 검색
  • 관심사를 정리하고 뉴스 연구, 임상 실험 및 특허를 통해 최신 정보를 확인하세요.

증상이나 질병을 입력하고 도움이 될 수있는 약초에 대해 읽고 약초를 입력하고 사용되는 질병과 증상을 확인합니다.
* 모든 정보는 발표 된 과학 연구를 기반으로합니다.

Google Play badgeApp Store badge